Attenuated isolate of infectious bronchitis virus strain dmv1639
AssigneeUniversity of Georgia Research Foundation, Inc.
InventorsMark W. Jackwood, Brian J. Jordan
Life of this patent
Estimating the term…
Abstract
A heat attenuated infectious bronchitis virus (IBV) isolate of PDRC DMV/1639 deposited at the ATCC under Patent Designation PTA-12657 an progeny and derivatives thereof and compositions thereof are presented. Methods for administering the isolates and compositions as vaccines to the prevent virulent IBV infection in birds of the order Galliformes are also presented.
Claims20
An infectious bronchitis virus (IBV) isolate, wherein the IBV isolate comprises the heat attenuated IBV isolate PDRC DMV/1639 deposited at the ATCC under Patent Designation PTA-12657 or a progeny or derivative thereof, wherein a progeny or derivative thereof has essentially the same biological and serological characteristics of the heat attenuated IBV isolate PDRC DMV/1639 deposited at the ATCC under Patent Designation PTA-12657.
A vaccine for birds of the order Galliformes comprising an amount of the heat attenuated IBV isolate PDRC DMV/1639 deposited at the ATCC under Patent Designation PTA-12657, or a progeny or derivative thereof, sufficient to protect the birds from one or more clinical signs induced by an infectious bronchitis virus (IBV) infection in poultry.
Dependencies are inferred from the claim text.